| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/21/2002 | EP0567577B1 Nucleotide sequences coding for the murine adrenergenic beta 3 receptor and applications thereof |
| 08/21/2002 | EP0537160B1 Expression of recombinant hemoglobin in yeast |
| 08/21/2002 | CN1365392A Drosophila recombination-associated protein and methods for use |
| 08/21/2002 | CN1365391A Mammalian cytokines and related reagents |
| 08/21/2002 | CN1364874A Stem and ancestral cell suspension for embryo hematogenesis and its preparing method and use |
| 08/20/2002 | US6437221 Dna sequence encoding capsicum anuum fibrillin gene promoter capable of driving gene expression |
| 08/20/2002 | US6437220 Nucleic acid with transcription regulatory sequence; modulation of fatty acid production in plants |
| 08/20/2002 | US6437218 Altered epicuticular wax |
| 08/20/2002 | US6437114 Human dopamine receptor and uses |
| 08/20/2002 | US6437111 Bone morphogenetic protein-11 (BMP-11) compositions |
| 08/20/2002 | US6437110 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/20/2002 | US6437098 Genetic engineering; anticarcinogenic agents; side effect reduction |
| 08/20/2002 | US6437096 Diagnosing infections; vaccines; genetic engineering and expression |
| 08/20/2002 | US6436907 Adenovirus-medicated gene transfer to cardiac and vascular smooth muscle |
| 08/20/2002 | US6436903 Immunomodulating compounds comprising d-isomers of amino acids |
| 08/20/2002 | US6436707 Trap cassette and splice acceptor; polyadenylation sequence defining 3' end of first exon; high speed screening; gene expression |
| 08/20/2002 | US6436705 Shape stabilized erythrocytes |
| 08/20/2002 | US6436704 Cell differentiation into acinar, ductal, and islet cells; immunogens; bioassays |
| 08/20/2002 | US6436703 Polynucleotide; genetic engineering and gene expression; cloning, molecular hybridization; medical diagnosis |
| 08/20/2002 | US6436701 Derivation of pluripotential embryonic cell lines from ungulate species |
| 08/20/2002 | US6436693 Using dna helper virus vector dna mutated so that cis-acting signal sequences for packaging of dna are non-functional; helper virus dna may provide information necessary for production of viral particles but may not be packaged therein |
| 08/20/2002 | US6436692 Isolated nucleic acid molecule encoding 3-hydroxy-3-methylglutaryl coenzyme a synthase, consisting of selected nucleotide sequence |
| 08/20/2002 | US6436688 Isolated dna molecule having nucleotide sequence encoding polypeptide having specified amino acid sequence |
| 08/20/2002 | US6436686 Isolated microtubule motor protein having microtubule stimulated adenosine triphosphatase activity and having greater than 90% amino acid sequence identity to specified sequence as measured using sequence comparison algorithm |
| 08/20/2002 | US6436684 Isolated nucleic acid molecule consisting of selected nucleotide sequence encoding phenol sulfotransferase protein |
| 08/20/2002 | US6436682 Isolated substantially purified gaussia, renilla mulleri or pleuromamma luciferase protein encoded by specified nucleotide sequences |
| 08/20/2002 | US6436681 Method for producing biotin |
| 08/20/2002 | US6436673 Isolated polynucleotide encoding neuronal-activity regulated pentraxin, narp, polypeptide having specified amino acid sequence |
| 08/20/2002 | US6436672 Polynucleotides encoding a type V adenylyl cyclase |
| 08/20/2002 | US6436642 Method of classifying a thyroid carcinoma using differential gene expression |
| 08/20/2002 | US6436634 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 08/20/2002 | US6436410 DNA encoding neospora dihydrofolate reductase-thymidylate synthase |
| 08/20/2002 | US6436394 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 08/20/2002 | US6436392 Dna segment confers increased episomal stability, persistence or abundance of the isolated dna molecule in a host cell |
| 08/20/2002 | US6436387 Methods of ex-vivo expansion of hematopoietic cells using multivariant IL-3 hematopoiesis chimera proteins |
| 08/20/2002 | CA2203991C Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| 08/20/2002 | CA2165678C Plants having modified response to ethylene |
| 08/20/2002 | CA2098404C Improved humanized immunoglobulins |
| 08/20/2002 | CA2006865C Humanized immunoglobulins and their production and use |
| 08/15/2002 | WO2002063038A1 Method for identifying compounds modulating reverse cholesterol transport |
| 08/15/2002 | WO2002063036A2 Vector system used in screening active substances |
| 08/15/2002 | WO2002063027A1 Multi-sample fermentor and method of using same |
| 08/15/2002 | WO2002063024A2 Sustained totipotent culture of selected monocot genera |
| 08/15/2002 | WO2002063018A2 Method for the production of plant seed with modified fibre content and modified seed coat |
| 08/15/2002 | WO2002063012A2 Ragweed allergens |
| 08/15/2002 | WO2002063010A2 Method of producing recombinant antibodies against tumors |
| 08/15/2002 | WO2002063008A2 Intracellular signaling molecules |
| 08/15/2002 | WO2002063007A2 TIMM8b-RELATED PROTEIN |
| 08/15/2002 | WO2002063006A2 Receptors and membrane-associated proteins |
| 08/15/2002 | WO2002063005A2 Lipid-associated molecules |
| 08/15/2002 | WO2002063004A2 G-protein coupled receptors |
| 08/15/2002 | WO2002062999A2 Proteins and nucleic acids encoding same |
| 08/15/2002 | WO2002062973A2 Lipase variants |
| 08/15/2002 | WO2002062972A2 Hybridoma cell line g250 and its use for producing monoclonal antibodies |
| 08/15/2002 | WO2002062971A1 Method of isolating epithelial cells, method of preconditioning cells, and methods of preparing bioartificial skin and dermis with the epithelial cells or the preconditioned cells |
| 08/15/2002 | WO2002062970A1 Enteric nervous system derived stem and progenitor cells and uses thereof |
| 08/15/2002 | WO2002062969A2 Cellular reprogramming in peptide hydrogel and uses thereof |
| 08/15/2002 | WO2002062968A2 Micro-tubular materials and cell constructs |
| 08/15/2002 | WO2002062967A2 Multipotent o-2a progenitors from the neurohypophysis |
| 08/15/2002 | WO2002062965A2 Method for identifying intercellular protein factors |
| 08/15/2002 | WO2002062961A2 Peptide scaffold encapsulation of tissue cells and uses thereof |
| 08/15/2002 | WO2002062959A2 Hepatitis b virus treatment |
| 08/15/2002 | WO2002062957A2 Ter sites and ter binding proteins |
| 08/15/2002 | WO2002062952A2 Non-cytotoxic pap mutants |
| 08/15/2002 | WO2002062945A2 Compositions and methods relating to lung specific genes and proteins |
| 08/15/2002 | WO2002062851A1 Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 08/15/2002 | WO2002062847A2 Superficial zone protein and methods of making and using same |
| 08/15/2002 | WO2002062841A2 Secreted proteins |
| 08/15/2002 | WO2002062840A1 INTERFERON-α INDUCED GENE |
| 08/15/2002 | WO2002062837A2 Cells with enhanced pkr expression for increasing cytokine production |
| 08/15/2002 | WO2002062825A2 Detection of polymorphisms in the human 5-lipoxygenase gene |
| 08/15/2002 | WO2002062395A2 A method and system for introducing a gene into a human stem cell |
| 08/15/2002 | WO2002062358A1 Cell suspension preparation technique and device |
| 08/15/2002 | WO2002062357A1 Methods and devices for tissue repair |
| 08/15/2002 | WO2002062297A2 Methods and compositions for modulating gluconeogenesis using pgc-1 |
| 08/15/2002 | WO2002062205A2 Methods for diagnosing and treating heart disease |
| 08/15/2002 | WO2002062204A2 Methods for diagnosing and treating heart disease |
| 08/15/2002 | WO2002062135A2 Scce modified transgenic mammals and their use as models of human disease |
| 08/15/2002 | WO2002062134A1 Human sphingosine-1-phosphate phosphatase |
| 08/15/2002 | WO2002051871A3 Anti-cd28 antibody |
| 08/15/2002 | WO2002046404A9 Schizophrenia-related voltage-gated ion channel gene and protein |
| 08/15/2002 | WO2002039948A3 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 08/15/2002 | WO2002035990A3 Supported lattice for cell cultivation |
| 08/15/2002 | WO2002032937A3 Neuromedin u delta |
| 08/15/2002 | WO2002032419A3 Methods for modulating bladder function |
| 08/15/2002 | WO2002026939A3 Microfabrication of membranes for the growth of cells |
| 08/15/2002 | WO2002018554A3 Isolated human drug-metabolizing proteins, nucleic acid moleculesand uses thereof |
| 08/15/2002 | WO2002017980B1 Methods and compositions for tissue regeneration |
| 08/15/2002 | WO2002010345A3 Autologous bio-matrix from mammalian liver |
| 08/15/2002 | WO2002008751A3 Mild enrichment of foetal cells from peripheral blood and use thereof |
| 08/15/2002 | WO2001096875A9 Hcv antigen/antibody combination assay |
| 08/15/2002 | WO2001092321A3 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes |
| 08/15/2002 | WO2001085995A9 Identification of neural defects associated with the nucleosom al assembly protein 1l2 gene |
| 08/15/2002 | WO2001081551A9 Retinal pigment epithelial cell lines with extended life-span and their applications |
| 08/15/2002 | WO2001066753A3 Human genes and gene expression products |
| 08/15/2002 | WO2001066572A9 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 08/15/2002 | WO2001040309A9 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 08/15/2002 | WO2001034801A9 Recombinant gelatin in vaccines |
| 08/15/2002 | WO2001032927A3 Tissue specific genes of diagnostic import |
| 08/15/2002 | WO2001032843A9 Enhanced immune recognition of pathogenic cells by icsbp expression |